Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065773

President sold 15,000 shares at an average $57.93 ($868,897)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-12-31 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-31 Sale −7,976 $57.56 $459,099 7,024 D
RUBINSTEIN JULIE President 2020-12-31 Sale −6,386 $58.25 $371,985 638 D
RUBINSTEIN JULIE President 2020-12-31 Sale −638 $59.27 $37,814 0 D
Derivatives
RUBINSTEIN JULIE President 2020-12-31 Option exercise · Stock Option (Right to Buy) −15,000 380,000 D
Open-market sales · 15,000 sh · avg $57.93 · $868,897
Loading xslF345X03/doc4.xml…